Leuprolide
Who holds supplier records for Leuprolide? 10 organisations hold a current record for Leuprolide: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 10 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (2), Netherlands (1), Spain (1), United States (1) and 4 other countries (4); not recorded for 1.
Most records are filed under another form of this substance: Leuprolide Acetate (14 current sources). A DMF or CEP is listed under the form it names.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Leuprolide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/leuprolide
Reading the evidence
- 10 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 7 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Leuprolide expires 22 Dec 2041. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (10)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Leuprolide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ASPEN OSS BVNetherlandsCEP Company GMP cert on recordActive DMF 17243 · latest filing Mar 2004
- BCN PEPTIDES SASpainCEPActive DMF 26716 · latest filing Dec 2012
- POLYPEPTIDE LABORATORIES INCUnited StatesCEPActive DMF 13150 · latest filing Aug 1998
- BACHEM AGCEP Company GMP cert on record
- ItalyCEP Company GMP cert on record
- IndiaCEP Company GMP cert on record
- PolyPeptide Laboratories (Sweden) ABSwedenCEP Company GMP cert on record
- IndiaCEP Company GMP cert on record
- JapanCEP Company GMP cert on record
- ChinaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (10)
Certificates of Suitability on the EDQM register for Leuprolide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 15 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai | IN | CEP 2014-278 - Rev 02 Leuprorelin | Mar 2026 | — |
| POLYPEPTIDE LABORATORIES (SWEDEN) AB Limhamn | SE | CEP 2011-321 - Rev 03 Leuprorelin, Process F | Jan 2026 | Inspected Jan 2025 Sweden |
| CHEMI S.P.A. Patrica | IT | CEP 2008-115 - Rev 05 Leuprorelin | Sept 2025 | Inspected Jul 2025 Italy |
| PIRAMAL PHARMA LIMITED Navi Mumbai | IN | CEP 2011-274 - Rev 02 Leuprorelin | Mar 2024 | Inspected May 2024 Italy |
| BCN PEPTIDES S.A. St Quinti De Mediona | ES | R1-CEP 2017-193 - Rev 00 Leuprorelin | Dec 2022 | — |
| ASPEN OSS B.V. Oss | NL | R1-CEP 2016-199 - Rev 00 Leuprorelin | Aug 2022 | — |
| Takeda Pharmaceutical Company, Limited Osaka | JP | R1-CEP 2001-441 - Rev 03 Leuprorelin | Jul 2022 | — |
| ZHEJIANG PEPTITES BIOTECH CO., LTD. Sanjie Town | CN | R0-CEP 2020-305 - Rev 00 Leuprorelin | Mar 2022 | — |
| Bachem AG Bubendorf | CH | R1-CEP 2001-454 - Rev 01 Leuprorelin | Feb 2009 | — |
| PolyPeptide Laboratories Inc. Torrance | US | R1-CEP 2003-045 - Rev 00 Leuprorelin | Feb 2009 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (2)
Organisations whose Type II DMFs for Leuprolide are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- United States · Inactive DMF 26380 · filed Sept 2012
- PENINSULA LABS INCInactive DMF 13922 · filed Dec 1998
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (28 listed products contain Leuprolide). The latest listed patent expires 22 Dec 2041. The latest listed exclusivity runs to 25 Aug 2028. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Leuprolide is a protein active pharmaceutical ingredient (ChEMBL CHEMBL1201199).
Chemical identity
- IUPAC name
- (2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
- Canonical SMILES
- CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6
- InChIKey
- GFIJNRVAKGFPGQ-LIJARHBVSA-N
- Synonyms
- ABBOTT-43818 FREE BASE, CKD-841, Leuporelin, (-)-leuprolide, Leuprolide, Leuprorelin, Leuprorelina, Leuproreline, Leuprorelin slow release, NSC-377526, TAP-144 FREE BASE, Leuprorelinum
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Leuprolide?
10 organisations hold an active US FDA Type II Drug Master File or a CEP for Leuprolide: ASPEN OSS BV (Netherlands), BCN PEPTIDES SA (Spain), POLYPEPTIDE LABORATORIES INC (United States), BACHEM AG, CHEMI SPA (Italy), Piramal Pharma Limited (India), PolyPeptide Laboratories (Sweden) AB (Sweden) and Sun Pharmaceutical Industries Limited (India), and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Leuprolide Drug Master Files are active?
ASPEN OSS BV (DMF 17243), BCN PEPTIDES SA (DMF 26716) and POLYPEPTIDE LABORATORIES INC (DMF 13150). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Leuprolide records mean?
2 organisations have only inactive Type II DMFs for Leuprolide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Leuprolide have a European Certificate of Suitability?
Yes. 10 organisations hold a valid CEP for Leuprolide on the EDQM register, including SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai (IN), POLYPEPTIDE LABORATORIES (SWEDEN) AB Limhamn (SE), CHEMI S.P.A. Patrica (IT), PIRAMAL PHARMA LIMITED Navi Mumbai (IN), BCN PEPTIDES S.A. St Quinti De Mediona (ES) and ASPEN OSS B.V. Oss (NL) and 4 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Leuprolide?
Yes. The latest patent listed for an approved US product containing Leuprolide expires 22 Dec 2041, across 28 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Leuprolide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Leuprolide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.